• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PRIME BRPL 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM PRIME BRPL 3D; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number APB-2-3-3D-ES
Device Problems Separation Failure (2547); Detachment of Device or Device Component (2907)
Patient Problem Foreign Body In Patient (2687)
Event Date 04/28/2022
Event Type  Injury  
Event Description
Medtronic received a report that after the detachment point reached the detachment zone, they manually detached the coil.They withdrew the push rod, and found that the coil was not detached.They repeatedly adjusted the position of the microcatheter, push rod and coil for half an hour but it still did not detach.They decided to withdraw the coil to vitro, on the way to withdraw, the coil detached.The coil went in the blood vessel and ran to the distal of the blood vessel with the blood flow.The devices were prepared as indicated in the ifu.There were no patient symptoms or complications associated with the event.The patient was undergoing surgery for treatment of a saccular, unruptured aneurysm in the left side a1 with a max diameter of 5*3mm and a 3mm neck diameter.It was noted the patient's blood flow was normal and vessel tortuosity was moderate.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received reported that the coil was not implanted in the intended location as it escaped to the distal blood vessel.No additional medical/surgical intervention was required.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
H3: the axium prime coil was returned for analysis.The axium prime pusher was found broken at the manual detachment location via hypotube break indicator (hbi).The release wire was not found extending out from within the broken end.The pusher was found bent at 32.0cm from the distal end of pusher.The pusher release wire coin was found not at the lumen stop, the shield coil was found stretched, and the implant coil was detached from the pusher.The detached implant coil was not returned as it remains within the patient.The release wire could not be located within the pusher; therefore, an analysis could not be performed.There was a appearance of dried residue within the pusher lumen stop.The pusher was placed in the sonic cleaner to remove the residue.After cleaning, the pusher¿s lumen stop and retainer ring inner diameters (id) were found in good condition.The lumen stop id could not be measured as residue was still within the id.The retainer ring id was measured to be 0.0046¿ which is within specification (specification: 0.00455" ± 0.00010).Based on the device analysis and reported information, the customer¿s ¿premature detachment from non-detachment¿ report was confirmed.In the event it is likely the bends at the distal end of the pusher contributed to the non-detachment issue.The pusher can become bent if advanced against resistance.In addition, as the coil shield was found stretched it is possible the coil shield became wrapped around the coil shell or proximal end of implant coil contributing to the events.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM PRIME BRPL 3D
Type of Device
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key14274396
MDR Text Key294653418
Report Number2029214-2022-00751
Device Sequence Number1
Product Code KRD
UDI-Device Identifier00763000313685
UDI-Public00763000313685
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K151447
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 08/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAPB-2-3-3D-ES
Device Catalogue NumberAPB-2-3-3D-ES
Device Lot Number222493628
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 04/28/2022
Initial Date FDA Received05/04/2022
Supplement Dates Manufacturer Received05/06/2022
07/16/2022
Supplement Dates FDA Received06/01/2022
08/10/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/28/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
Patient SexMale
Patient Weight75 KG
-
-